Lorafen

GIF decision: Marketing suspension

What does this decision mean?

  • Wstrzymanie w obrocie — The product has been temporarily suspended from circulation — sales are paused pending clarification, but it is not a full market recall.

An out-of-specification result was found in long-term stability testing (parameter: active substance release below the lower acceptance limit), which constitutes a real and direct threat to patients' health or life. Potential effects: reduced treatment efficacy, disease exacerbation, complications endangering health or life.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Lorafen
Risk Level
High
Manufacturer
Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
Batch Number
41124, 51124
Notice Date
17.12.2025
View official statement
Source: GIF view the official alert

What to do if you have this product?

A recall means the product may be unsafe. Here is what to do if you have it at home.

  1. 1

    Do not eat or use the product

    Stop using or consuming it immediately and keep it out of reach of children.

  2. 2

    Check the batch number and expiry date

    Compare the batch/lot number and the best-before or expiry date with the details in the alert — sometimes only specific batches are affected.

  3. 3

    Return it to the shop

    You can take the product back to the shop where you bought it. For a safety recall a refund is due even without a receipt.

  4. 4

    Get help and report it

    If you feel unwell after using the product, contact a doctor. You can also report the case to the relevant authority — GIS, GIF or UOKiK.

General guidance for recalled products in Poland. Always follow the specific instructions in the official alert and from the manufacturer or retailer.

Important Information

What You Should Know

Recommendations

Do not use Lorafen, 1 mg, coated tablets from batches 41124 and 51124. If you have packs from these batches, consult your doctor or pharmacist to determine further steps and possible replacement of t...

Actions Taken

The Chief Pharmaceutical Inspector suspended the marketing of Lorafen, 1 mg, coated tablets in Poland for batches 41124 and 51124. The decision was given immediate enforceability. The marketing auth...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

Related

Other Notices